Responses
Regular and young investigator award abstracts
Clinical trials completed
272 Use of LioCyx-M, autologous hepatitis B virus (HBV)-Specific T cell receptor (TCR) T-cells, in advanced HBV-related hepatocellular carcinoma (HCC)
Compose a Response to This Article
Other responses
No responses have been published for this article.